(Q38455476)

3 September 2017

Differential expression of bcl-2 family proteins in bladder carcinomas. Relationship with apoptotic rate and survival (English)

1 reference

3 September 2017

0 references

Penelope Korkolopoulou

1

1 reference

3 September 2017

Andreas Ch Lazaris

2

1 reference

3 September 2017

Anastasia-E Konstantinidou

3

1 reference

3 September 2017

Nikolaos Kavantzas

4

1 reference

3 September 2017

Efstratios Patsouris

5

1 reference

3 September 2017

Panayota Christodoulou

6

1 reference

3 September 2017

Euphemia Thomas-Tsagli

7

1 reference

3 September 2017

Panagiotis Davaris

8

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

3 September 2017

1 reference

3 September 2017

41

1 reference

3 September 2017

274-283

1 reference

3 September 2017

3

1 reference

Programmed cell death: apoptosis and oncogenesis.

3 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900003-9

7 January 2021

Apoptosis in the pathogenesis and treatment of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900003-9

7 January 2021

Checkpoints of dueling dimers foil death wishes

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900003-9

7 January 2021

Anchorage dependence, integrins, and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900003-9

7 January 2021

c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900003-9

7 January 2021

Invasion of the bladder by transitional cell carcinoma: its relation to histologic grade and expression of p53, MIB-1, c-erb B-2, epidermal growth factor receptor, and bcl-2

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900003-9

7 January 2021

The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900003-9

7 January 2021

Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900003-9

7 January 2021

Apoptosis in bladder carcinomas detected with monoclonal antibody to single-stranded DNA: relation to cell cycle regulators and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900003-9

7 January 2021

Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900003-9

7 January 2021

Expression of the apoptosis suppressing bcl-2 protein in transitional cell bladder tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900003-9

7 January 2021

Bcl-2/bax mRNA expression ratio as prognostic factor in low-grade urinary bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900003-9

7 January 2021

Monoclonal antibody to single-stranded DNA is a specific and sensitive cellular marker of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900003-9

7 January 2021

Apoptosis in bladder cancer as related to standard prognostic factors and prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900003-9

7 January 2021

Clinical significance of mdm2 and p53 expression in bladder cancer. A comparison with cell proliferation and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900003-9

7 January 2021

The spontaneous apoptotic cell death of normal human lymphocytes in vitro: the release of, and immunoproliferative response to, nucleosomes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900003-9

7 January 2021

Detection of p53 and bcl-2 protein in carcinoma of the renal pelvis and ureter including dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900003-9

7 January 2021

The role of bcl-2, p53, and ki-67 index in predicting tumor recurrence for low grade superficial transitional cell bladder carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900003-9

7 January 2021

The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900003-9

7 January 2021

Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900003-9

7 January 2021

Immunohistochemical evaluation of p53, proliferating cell nuclear antigen (PCNA) and bcl-2 expression during bacillus Calmette-Guerin (BCG) intravesical instillation therapy for superficial bladder cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900003-9

7 January 2021

Reciprocal expression of bcl-2 and p53 oncoproteins in urothelial dysplasia and carcinoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900003-9

7 January 2021

Prognostic value of Bcl-2 and p53 expression in urinary tract transitional cell cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900003-9

7 January 2021

Relationship of p53 and bcl-2 to prognosis in muscle-invasive transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900003-9

7 January 2021

Factors Influencing the Survival of Patients with Transitional Cell Tumours of the Urinary Bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900003-9

7 January 2021

10.1016/S0302-2838(02)00003-9

Identifiers

DOI

1 reference

3 September 2017

1 reference